New FDA tri­al in­no­va­tion cen­ter launch­es with demon­stra­tion to in­crease in­dus­try in­ter­ac­tions

The FDA on Mon­day launched a new hub fo­cused on in­no­vat­ing in clin­i­cal tri­als as part of wider ef­forts to make drug de­vel­op­ment more ef­fi­cient.

The new Cen­ter for Clin­i­cal Tri­al In­no­va­tion (C3TI) will fo­cus on im­ple­ment­ing lessons al­ready gleaned from CDER’s work in the area and will give clin­i­cal tri­al spon­sors ad­di­tion­al ac­cess to staff to dis­cuss tri­al de­signs. Specif­i­cal­ly, the new hub will fo­cus on keep­ing spon­sors up to speed with cur­rent in­no­va­tions, bol­ster­ing tri­al par­tic­i­pant di­ver­si­ty, and im­prov­ing clin­i­cal tri­al da­ta.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER